The report analyzes and forecasts the Thin film drug manufacturing market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level. For the region and all segments, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.
This report first introduces the background of Thin film drug manufacturing, including the definition, classification, application, industrial chain structure, industry overview, national policy and planning analysis of the industry, and the latest dynamic analysis. With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Thin film drug manufacturing companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Thin film drug manufacturing upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of Thin film drug manufacturing and consumption, major regions and consumption, major global producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global Thin film drug manufacturing market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the Thin film drug manufacturing market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of Thin film drug manufacturing market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Key Players Mentioned in this Report are:
The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global thin film drug manufacturing market. The report also profiles key players operating in the thin film drug manufacturing market which are Pfizer, Inc., Novartis AG, Allergan plc, Wolters Kluwer, Solvay, IntelGenx Corp., Sumitomo Dainippon Pharma Co., Ltd., Indivior plc and ZIM Laboratories Limited
The global thin film drug manufacturing market is segmented as follows:
Global Thin Film Drug Manufacturing Market, by Product Type
Global Thin Film Drug Manufacturing Market, by Disease Indication
Global Thin Film Drug Manufacturing Market, by Geography
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are:
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Key Market Indicators
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunity
4.5. Global Thin Film Drug Manufacturing Analysis and Forecasts, 2016–2026
4.6. Thin Film Drug Manufacturing - Global Supply Demand Scenario
4.7. Porter’s Five Force Analysis
4.8. Value Chain Analysis
4.9. Market Outlook
5. Global Thin Film Drug Manufacturing Analysis and Forecasts, By Product
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Key Trends
5.4. Market Value Forecast By Product, 2016–2026
5.4.1. Oral Thin Film
5.4.1.1. Sublingual film
5.4.1.2. Fully dissolving dental/ buccal film
5.4.2. Transdermal Thin Film
5.4.3. Others
5.5. Product Comparison Matrix
5.6. Market Attractiveness By Product
5.7. Oral Thin Film Drugs : Key market insights
5.7.1. Pipeline Analysis
5.7.2. Technology Insights
5.7.3. Key Product Insights
6. Global Thin Film Drug Manufacturing Analysis and Forecasts, By Distribution Channel
6.1. Introduction & Definition
6.2. Key Findings
6.3. Market Value Forecast By Distribution Channel, 2016–2026
6.3.1. Hospital Pharmacies
6.3.2. Drug Stores
6.3.3. Retail Pharmacies
6.3.4. E- Commerce
6.4. Distribution Channel Comparison Matrix
6.5. Market Attractiveness By Distribution Channel
7. Global Thin Film Drug Manufacturing Analysis and Forecasts, By Disease Indication
7.1. Introduction & Definition
7.2. Key Findings
7.3. Key Trends
7.4. Market Value Forecast By Disease Indication, 2016–2026
7.4.1. Schizophrenia
7.4.2. Migraine
7.4.3. Opioid Dependence
7.4.4. Nausea & Vomiting
7.4.5. Others
7.5. Disease Indication Comparison Matrix
7.6. Market Attractiveness By Disease Indication
8. Global Thin Film Drug Manufacturing Analysis and Forecasts, By Region
8.1. Introduction & Definition
8.2. Key Findings
8.3. Market Value Forecast By Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Asia Pacific
8.3.4. Europe
8.3.5. Middle East & Africa
8.4. Market Attractiveness By Country/Region
9. North America Thin Film Drug Manufacturing Analysis and Forecast
9.1. Introduction
9.2. Market Value Forecast By Product, 2016–2026
9.2.1. Oral Thin Film
9.2.1.1. Sublingual film
9.2.1.2. Fully dissolving dental/ buccal film
9.2.2. Transdermal Thin Film
9.2.3. Others (Ocular Thin Film, etc.)
9.3. Market Value Forecast By Distribution Channel, 2016–2026
9.3.1. Hospital Pharmacies
9.3.2. Drug Stores
9.3.3. Retail Pharmacies
9.3.4. E- Commerce
9.4. Market Value Forecast By Disease Indication, 2016–2026
9.4.1. Schizophrenia
9.4.2. Migraine
9.4.3. Opioid Dependence
9.4.4. Nausea & Vomiting
9.4.5. Others
9.5. Market Value Forecast By Country, 2016–2026
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Product
9.6.2. By Distribution Channel
9.6.3. By Disease Indication
9.6.4. By Country
10. Latin America Thin Film Drug Manufacturing Analysis and Forecast
10.1. Introduction
10.2. Market Value Forecast By Product, 2016–2026
10.2.1. Oral Thin Film
10.2.1.1. Sublingual film
10.2.1.2. Fully dissolving dental/ buccal film
10.2.2. Transdermal Thin Film
10.2.3. Others (Ocular Thin Film, etc.)
10.3. Market Value Forecast By Distribution Channel, 2016–2026
10.3.1. Hospital Pharmacies
10.3.2. Drug Stores
10.3.3. Retail Pharmacies
10.3.4. E- Commerce
10.4. Market Value Forecast By Disease Indication, 2016–2026
10.4.1. Schizophrenia
10.4.2. Migraine
10.4.3. Opioid Dependence
10.4.4. Nausea & Vomiting
10.4.5. Others
10.5. Market Value Forecast By Country, 2016–2026
10.5.1. Brazil
10.5.2. Mexico
10.5.3. Rest of Latin America
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Distribution Channel
10.6.3. By Disease Indication
10.6.4. By Country
11. Asia Pacific Thin Film Drug Manufacturing Analysis and Forecast
11.1. Introduction
11.2. Market Value Forecast By Product, 2016–2026
11.2.1. Oral Thin Film
11.2.1.1. Sublingual film
11.2.1.2. Fully dissolving dental/ buccal film
11.2.2. Transdermal Thin Film
11.2.3. Others (Ocular Thin Film, etc.)
11.3. Market Value Forecast By Distribution Channel, 2016–2026
11.3.1. Hospital Pharmacies
11.3.2. Drug Stores
11.3.3. Retail Pharmacies
11.3.4. E- Commerce
11.4. Market Value Forecast By Disease Indication, 2016–2026
11.4.1. Schizophrenia
11.4.2. Migraine
11.4.3. Opioid Dependence
11.4.4. Nausea & Vomiting
11.4.5. Others
11.5. Market Value Forecast By Country, 2016–2026
11.5.1. Japan
11.5.2. India
11.5.3. China
11.5.4. Rest Of Asia Pacific
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Distribution Channel
11.6.3. By Disease Indication
11.6.4. By Country
12. Europe Thin Film Drug Manufacturing Analysis and Forecast
12.1. Introduction
12.2. Market Value Forecast By Product, 2016–2026
12.2.1. Oral Thin Film
12.2.1.1. Sublingual film
12.2.1.2. Fully dissolving dental/ buccal film
12.2.2. Transdermal Thin Film
12.2.3. Others (Ocular Thin Film, etc.)
12.3. Market Value Forecast By Distribution Channel, 2016–2026
12.3.1. Hospital Pharmacies
12.3.2. Drug Stores
12.3.3. Retail Pharmacies
12.3.4. E- Commerce
12.4. Market Value Forecast By Disease Indication, 2016–2026
12.4.1. Schizophrenia
12.4.2. Migraine
12.4.3. Opioid Dependence
12.4.4. Nausea & Vomiting
12.4.5. Others
12.5. Market Value Forecast By Country, 2016–2026
12.5.1. France
12.5.2. Germany
12.5.3. Italy
12.5.4. Spain
12.5.5. Russia
12.5.6. Rest Of Europe
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Distribution Channel
12.6.3. By Disease Indication
12.6.4. By Country
13. Middle East & Africa Thin Film Drug Manufacturing Analysis and Forecast
13.1. Introduction
13.2. Market Value Forecast By Product, 2016–2026
13.2.1. Oral Thin Film
13.2.1.1. Sublingual film
13.2.1.2. Fully dissolving dental/ buccal film
13.2.2. Transdermal Thin Film
13.2.3. Others (Ocular Thin Film, etc.)
13.3. Market Value Forecast By Distribution Channel, 2016–2026
13.3.1. Hospital Pharmacies
13.3.2. Drug Stores
13.3.3. Retail Pharmacies
13.3.4. E- Commerce
13.4. Market Value Forecast By Disease Indication, 2016–2026
13.4.1. Schizophrenia
13.4.2. Migraine
13.4.3. Opioid Dependence
13.4.4. Nausea & Vomiting
13.4.5. Others
13.5. Market Value Forecast By Country, 2016–2026
13.5.1. South Africa
13.5.2. Saudi Arabia
13.5.3. UAE
13.5.4. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Distribution Channel
13.6.3. By Disease Indication
13.6.4. By Country
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of companies)
14.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
14.2.1. ZIM Laboratories Limited
14.2.1.1. Company Details
14.2.1.2. Business Overview
14.2.1.3. Financial Overview
14.2.1.4. Strategic Overview
14.2.1.5. SWOT Analysis
14.2.2. Indivior plc.
14.2.2.1. Company Details
14.2.2.2. Business Overview
14.2.2.3. Financial Overview
14.2.2.4. Strategic Overview
14.2.2.5. SWOT Analysis
14.2.3. MonoSol Rx Allergan plc.
14.2.3.1. Company Details
14.2.3.2. Business Overview
14.2.3.3. Financial Overview
14.2.3.4. Strategic Overview
14.2.3.5. SWOT Analysis
14.2.4. Sumitomo Dainippon Pharma Co., Ltd.
14.2.4.1. Company Details
14.2.4.2. Business Overview
14.2.4.3. Financial Overview
14.2.4.4. Strategic Overview
14.2.4.5. SWOT Analysis
14.2.5. IntelGenx Corp
14.2.5.1. Company Details
14.2.5.2. Business Overview
14.2.5.3. Financial Overview
14.2.5.4. Strategic Overview
14.2.5.5. SWOT Analysis
14.2.6. Pfizer, Inc.
14.2.6.1. Company Details
14.2.6.2. Business Overview
14.2.6.3. Financial Overview
14.2.6.4. Strategic Overview
14.2.6.5. SWOT Analysis
14.2.7. Novartis AG
14.2.7.1. Company Details
14.2.7.2. Business Overview
14.2.7.3. Financial Overview
14.2.7.4. Strategic Overview
14.2.7.5. SWOT Analysis
14.2.8. Allergan plc.
14.2.8.1. Company Details
14.2.8.2. Business Overview
14.2.8.3. Financial Overview
14.2.8.4. Strategic Overview
14.2.8.5. SWOT Analysis
14.2.9. NAL Pharma
14.2.9.1. Company Details
14.2.9.2. Business Overview
14.2.9.3. Financial Overview
14.2.9.4. Strategic Overview
14.2.9.5. SWOT Analysis
14.2.10. Wolters Kluwer
14.2.10.1. Company Details
14.2.10.2. Business Overview
14.2.10.3. Financial Overview
14.2.10.4. Strategic Overview
14.2.10.5. SWOT Analysis
14.2.11. Solvay
14.2.11.1. Company Details
14.2.11.2. Business Overview
14.2.11.3. Financial Overview
14.2.11.4. Strategic Overview
14.2.11.5. SWOT Analysis
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers